Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 552

Results For "CE"

8162 News Found

Laurus Labs to increase stake in ImmunoACT to 33.86%
News | June 01, 2023

Laurus Labs to increase stake in ImmunoACT to 33.86%

This fresh infusion of capital will enable ImmunoACT to fast track the additional supply of the lead candidate HCAR-19


USFDA inspects contract manufacturing facility of Jubilant Pharmova at Montreal Canada
Drug Approval | June 01, 2023

USFDA inspects contract manufacturing facility of Jubilant Pharmova at Montreal Canada

The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.


Honeywell refurbishes PHCs in rural India across three states
Healthcare | June 01, 2023

Honeywell refurbishes PHCs in rural India across three states

The project is part of a three-year-long partnership between Honeywell and Americares to strengthen the health infrastructure in rural Maharashtra, Uttarakhand and Haryana


Glenmark sets GHG emission targets for FY2035
Sustainability | June 01, 2023

Glenmark sets GHG emission targets for FY2035

The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock


HMD supplied 1.75 billion syringes of the total 13.3 billion COVID 19 vaccines administered globally
News | June 01, 2023

HMD supplied 1.75 billion syringes of the total 13.3 billion COVID 19 vaccines administered globally

HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date


PharmaLytica returns to Hyderabad
News | May 31, 2023

PharmaLytica returns to Hyderabad

With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South


Hikal posts FY23 PAT at Rs. 36 Cr
News | May 30, 2023

Hikal posts FY23 PAT at Rs. 36 Cr

Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22


Ind-Swift Laboratories reports FY23 PAT at Rs. 42.47 Cr
News | May 30, 2023

Ind-Swift Laboratories reports FY23 PAT at Rs. 42.47 Cr

The company reported lifetime high EBIDTA of Rs. 250 crores


Jubilant Pharmova posts Q4FY23 consolidated loss at Rs. 97.84 Cr
News | May 30, 2023

Jubilant Pharmova posts Q4FY23 consolidated loss at Rs. 97.84 Cr

The company has reported total income of Rs. 1682.45 crores during the period ended March 31, 2023


Wockhardt’s Q4 FY23 three fold jump in EBITDA over Q4 FY22
News | May 29, 2023

Wockhardt’s Q4 FY23 three fold jump in EBITDA over Q4 FY22

Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239